C

Cellectis SA
D

CLLS

2.50000
USD
0.49
(24.38%)
مغلق
حجم التداول
10,532
الربح لكل سهم
-1
العائد الربحي
-
P/E
-4
حجم السوق
250,813,073
أصول ذات صلة
AMGN
AMGN
-2.01
(-0.65%)
306.66 USD
BMY
BMY
-0.525
(-1.07%)
48.455 USD
C
CLDX
0.110
(0.47%)
23.360 USD
GILD
GILD
3.000
(2.65%)
116.210 USD
J
JAZZ
0.280
(0.24%)
118.280 USD
NVS
NVS
0.260
(0.22%)
117.680 USD
المزيد
الأخبار المقالات

العنوان: Cellectis SA

القطاع: Healthcare
الصناعة: Biotechnology
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.